|
UHPLC-MS/MS Single Run Quantification Method for Simultaneous Determination of Triazolopyrazine and N-Nitroso-Triazolopyrazine in Sitagliptin; Risk Assessment, Scavenger-Based Mitigation, and Stress Stability Study -Pub
|
|
0
|
109
|
May 20, 2026
|
|
Liquid Chromatography–High-Resolution Mass Spectrometric Determination of Nitrite Ion Concentration in the Natural Water Resources -Pub
|
|
0
|
95
|
May 20, 2026
|
|
Simultaneous Determination of Duloxetine and N-Nitroso-Duloxetine in Reactor Cleaning Solvent Samples by LC–HRMS: Formation, Quantitation, and Green -Pub
|
|
0
|
138
|
May 20, 2026
|
|
Analytical challenge for determination of instable standard of other N-nitroso structure
|
|
13
|
1294
|
May 18, 2026
|
|
Diluent Selection for Nitrosamine Impurities
|
|
7
|
424
|
May 8, 2026
|
|
How to overcome blank interference at NDBA
|
|
4
|
227
|
April 27, 2026
|
|
Maximum Daily Dose (MDD) of Cream Formulation
|
|
1
|
282
|
April 17, 2026
|
|
MDD for cream formulation
|
|
0
|
128
|
April 3, 2026
|
|
Analysis method of cream
|
|
6
|
345
|
March 30, 2026
|
|
Optimized UHPLC–Derivatization Method for Low-Level Nitrite Detection in Pharmaceutical Excipients-Pub
|
|
0
|
248
|
March 23, 2026
|
|
How to Validate High-Resolution Mass Spectrometry for Nitrosamine Detection in Pharmaceuticals
|
|
3
|
403
|
March 21, 2026
|
|
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide -Pub
|
|
4
|
382
|
March 19, 2026
|
|
Differences in Physical Form of Nitrosamine Reference Standards: USP vs. Other Suppliers
|
|
2
|
210
|
March 18, 2026
|
|
Scientific Clarification Request on Analytical Approach for Nitrosamine Determination in Quetiapine Oral Suspension
|
|
3
|
281
|
March 17, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol -
|
|
1
|
187
|
March 14, 2026
|
|
Testing of N-nitroso-cinacalcet
|
|
8
|
1244
|
March 14, 2026
|
|
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques-Pub
|
|
2
|
284
|
March 12, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol
|
|
3
|
300
|
March 11, 2026
|
|
Nitrosamine analysis in suspension dosage forms
|
|
5
|
326
|
March 6, 2026
|
|
N-Nitrosodibenzylamine infusion bags
|
|
0
|
133
|
February 27, 2026
|
|
Moxonidine Nitrosamines
|
|
6
|
335
|
February 25, 2026
|
|
N-nitroso-rivaroxaban amide
|
|
7
|
2159
|
February 4, 2026
|
|
Sufentanil Nitroso impurity standard
|
|
8
|
272
|
January 29, 2026
|
|
If NDSRIs are not detected at end of stability, is small-molecule nitrosamine testing still required?
|
|
5
|
313
|
January 23, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
475
|
January 20, 2026
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
288
|
December 10, 2025
|
|
Issue Regarding Purchase of N-Nitroso N-Desmethyl Rosuvastatin Reference Standard
|
|
5
|
356
|
December 10, 2025
|
|
Issue with Area Drop During N-Nitroso Dorzolamide Method Setup
|
|
3
|
248
|
December 10, 2025
|
|
N-Nitroso-Desmethyl-tetracycline MOA development
|
|
1
|
201
|
November 18, 2025
|
|
Determination of N-nitroso desmethyl Tetracycline
|
|
17
|
1260
|
October 27, 2025
|